Cargando…
Three- and six-month efficacy and safety of phentermine in a Mexican obese population
Objective: Mexico has the second largest prevalence of obesity among adults worldwide, a condition especially affecting the low-income population. There is a pressing need to improve therapeutic options for weight loss. Phentermine is an old and low-cost agent given as an adjuvant therapy for obesit...
Autores principales: | Márquez-Cruz, Maribel, Kammar-García, Ashuin, Huerta-Cruz, Juan Carlos, Carrasco-Portugal, Miriam del Carmen, Barranco-Garduño, Lina Marcela, Rodríguez-Silverio, Juan , Rocha González, Héctor Isaac, Reyes-García, Juan Gerardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dustri-Verlag Dr. Karl Feistle
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8295716/ https://www.ncbi.nlm.nih.gov/pubmed/34236303 http://dx.doi.org/10.5414/CP203943 |
Ejemplares similares
-
Weight Loss at First Month and Development of Tolerance as Possible Predictors of 30 mg Phentermine Efficacy at 6 Months
por: Rocha-González, Héctor Isaac, et al.
Publicado: (2021) -
Metformin improves the weight reduction effect of mazindol in prediabetic obese Mexican subjects
por: Arguelles-Tello, Federico Alberto, et al.
Publicado: (2022) -
Combined First Month Body Weight Loss and Development of Tolerance as Predictors of 6-Month Efficacy of Mazindol in Mild and Moderate Obese Subjects
por: Huerta-Cruz, Juan Carlos, et al.
Publicado: (2022) -
Estimation of vaccination coverage and associated factors in older Mexican adults
por: García-Hernández, Héctor, et al.
Publicado: (2023) -
Effect of the Melanocortin 4-Receptor Ile269Asn Mutation on Weight Loss Response to Dietary, Phentermine and Bariatric Surgery Interventions
por: Salazar-Valencia, Itzel G., et al.
Publicado: (2022)